RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |
| Rock Springs Capital Management LP | 1,597,123 | $36,614,045 | 0.98% |
| Baker Brothers Advisors | 6,702,349 | $153,651,351 | 0.89% |
| Nan Fung Group Holdings Ltd | 40,070 | $918,605 | 0.74% |
| Polar Capital Holdings Plc | 2,500,000 | $57,312,500 | 0.42% |
| Perceptive Advisors | 380,828 | $8,730,482 | 0.29% |
| Orbimed Advisors | 583,642 | $13,379,993 | 0.28% |
| Virtus ETF Advisers LLC | 17,193 | $394,150 | 0.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 157,426 | $3,608,991 | 0.23% |
| PRIMECAP MANAGEMENT CO/CA/ | 8,267,421 | $189,530,626 | 0.16% |
| FEDERATED HERMES, INC. | 2,341,335 | $53,675,105 | 0.14% |
External links
This page lists RHYTHM PHARMACEUTICALS INC's shareholders in Q3 2023. To view RHYTHM PHARMACEUTICALS INC's shareholder history, click here.